Taking everything into account, DBD scores 4 out of 10 in our fundamental rating. DBD was compared to 35 industry peers in the Technology Hardware, Storage & Peripherals industry. Both the profitability and the financial health of DBD get a neutral evaluation. Nothing too spectacular is happening here. DBD has a correct valuation and a medium growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year DBD was profitable.
In the past year DBD had a positive cash flow from operations.
DBD had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DBD reported negative operating cash flow in multiple years.

1.2 Ratios

DBD has a Return On Assets of 1.36%. This is in the better half of the industry: DBD outperforms 68.57% of its industry peers.
DBD has a Return On Equity of 4.57%. This is in the better half of the industry: DBD outperforms 80.00% of its industry peers.
The Return On Invested Capital of DBD (8.85%) is better than 71.43% of its industry peers.
DBD had an Average Return On Invested Capital over the past 3 years of 5.12%. This is significantly below the industry average of 16.06%.
The last Return On Invested Capital (8.85%) for DBD is above the 3 year average (5.12%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	1.36%
ROE	4.57%
ROIC	8.85%

ROA(3y)4.54%

ROA(5y)0.8%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)5.12%

ROIC(5y)5.58%

1.3 Margins

DBD's Profit Margin of 1.37% is fine compared to the rest of the industry. DBD outperforms 68.57% of its industry peers.
DBD's Operating Margin of 7.47% is fine compared to the rest of the industry. DBD outperforms 80.00% of its industry peers.
DBD's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 25.48%, DBD is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of DBD has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	7.47%
PM (TTM)	1.37%
GM	25.48%

OM growth 3Y20.78%

OM growth 5Y40.66%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.32%

GM growth 5Y0.68%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DBD is destroying value.
The number of shares outstanding for DBD remains at a similar level compared to 1 year ago.
Compared to 5 years ago, DBD has less shares outstanding
DBD has a better debt/assets ratio than last year.

2.2 Solvency

DBD has an Altman-Z score of 1.99. This is not the best score and indicates that DBD is in the grey zone with still only limited risk for bankruptcy at the moment.
DBD has a Altman-Z score (1.99) which is comparable to the rest of the industry.
DBD has a debt to FCF ratio of 3.71. This is a good value and a sign of high solvency as DBD would need 3.71 years to pay back of all of its debts.
The Debt to FCF ratio of DBD (3.71) is better than 68.57% of its industry peers.
DBD has a Debt/Equity ratio of 0.84. This is a neutral value indicating DBD is somewhat dependend on debt financing.
The Debt to Equity ratio of DBD (0.84) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.84
Debt/FCF	3.71
Altman-Z	1.99

ROIC/WACC0.94

WACC9.43%

2.3 Liquidity

A Current Ratio of 1.36 indicates that DBD should not have too much problems paying its short term obligations.
With a Current ratio value of 1.36, DBD perfoms like the industry average, outperforming 54.29% of the companies in the same industry.
DBD has a Quick Ratio of 1.36. This is a bad value and indicates that DBD is not financially healthy enough and could expect problems in meeting its short term obligations.
DBD's Quick ratio of 0.89 is in line compared to the rest of the industry. DBD outperforms 57.14% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.36
Quick Ratio	0.89

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for DBD have decreased strongly by -38.07% in the last year.
DBD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 69.69% yearly.
Looking at the last year, DBD shows a decrease in Revenue. The Revenue has decreased by -2.86% in the last year.
Measured over the past years, DBD shows a decrease in Revenue. The Revenue has been decreasing by -3.18% on average per year.

EPS 1Y (TTM)-38.07%

EPS 3Y69.69%

EPS 5YN/A

EPS Q2Q%150.91%

Revenue 1Y (TTM)-2.86%

Revenue growth 3Y-1.33%

Revenue growth 5Y-3.18%

Sales Q2Q%1.95%

3.2 Future

Based on estimates for the next years, DBD will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.21% on average per year.
DBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.51% yearly.

EPS Next Y8.85%

EPS Next 2Y12.85%

EPS Next 3Y19.21%

EPS Next 5YN/A

Revenue Next Year1.72%

Revenue Next 2Y1.93%

Revenue Next 3Y2.51%

Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.13 indicates a rather expensive valuation of DBD.
74.29% of the companies in the same industry are more expensive than DBD, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.21. DBD is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 14.24, which indicates a correct valuation of DBD.
DBD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DBD is cheaper than 71.43% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of DBD to the average of the S&P500 Index (24.26), we can say DBD is valued slightly cheaper.

		Industry Rank	Sector Rank
PE	19.13
Fwd PE	14.24

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DBD is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, DBD is valued cheaper than 82.86% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	9.98
EV/EBITDA	7.88

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DBD does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as DBD's earnings are expected to grow with 19.21% in the coming years.